NVCR
NVCR: Paravasthu Mukund discloses a sale
Paravasthu Mukund reported Sale in NovoCure Ltd: 3079.00 units of Ordinary Shares, dated 2026-11-09. The full Form 4 contains 1 transaction entry.
Cookies show us what works. Privacy
Cookies show us what works. Privacy
NVCR
Paravasthu Mukund reported Sale in NovoCure Ltd: 3079.00 units of Ordinary Shares, dated 2026-11-09. The full Form 4 contains 1 transaction entry.
AEIS
Donaghey John reported Sale in ADVANCED ENERGY INDUSTRIES INC: 3238 units of Common Stock, dated 2026-11-11. The full Form 4 contains 1 transaction entry.
FNF
Murren Heather Hay reported 6,217 shares of Common Stock in Fidelity National Financial, Inc. as grants or awards dated 2026-11-09. The Form 4 was disclosed on Nov 12, 2026. These were stock awards, not open-market purchases.
TEVA
Bergwerk Dov reported Grant or award in TEVA PHARMACEUTICAL INDUSTRIES LTD: 9433 units of Restricted Share Units (derivative), dated 2026-11-10. The full Form 4 contains 1 transaction entry.
FNF
Morgan Sandra Douglass reported 6,217 shares of Common Stock in Fidelity National Financial, Inc. as grants or awards dated 2026-11-09. The Form 4 was disclosed on Nov 12, 2026. These were stock awards, not open-market purchases.
ZVIA
Ruberti Alexandre reported Purchase in Zevia PBC: 81300 units of Class A Common Stock, dated 2026-11-09. The full Form 4 contains 1 transaction entry.
SELF
Zachary William Chester reported 2,748 shares of Common Stock in Global Self Storage, Inc. as grants or awards dated 2026-11-10. The Form 4 was disclosed on Nov 12, 2026. These were stock awards, not open-market purchases.
IRLA
Militello John reported Grant or award in IRulya Therapeutics Inc.: 80000 units of Common Stotck, dated 2026-11-09. The full Form 4 contains 1 transaction entry.
IRLA
Bonuccelli Catherine M. reported Grant or award in IRulya Therapeutics Inc.: 17000 units of Director Stock Option (Right to Buy) (derivative), dated 2026-11-09. The full Form 4 contains 1 transaction entry.
IRLA
PATTERSON LEONE D reported Grant or award in IRulya Therapeutics Inc.: 17000 units of Director Stock Option (Right to Buy) (derivative), dated 2026-11-09. The full Form 4 contains 1 transaction entry.
FNF
Rood John D reported 6,217 shares of Common Stock in Fidelity National Financial, Inc. as grants or awards dated 2026-11-09. The Form 4 was disclosed on Nov 12, 2026. These were stock awards, not open-market purchases.
IRLA
Valentine James Elwood reported Grant or award in IRulya Therapeutics Inc.: 17000 units of Director Stock Option (Right to Buy) (derivative), dated 2026-11-09. The full Form 4 contains 1 transaction entry.
IRLA
Wise John Drayton reported Grant or award in IRulya Therapeutics Inc.: 17000 units of Director Stock Option (Right to Buy) (derivative), dated 2026-11-09. The full Form 4 contains 1 transaction entry.
TEVA
Weiss Amir reported Exercise or conversion in TEVA PHARMACEUTICAL INDUSTRIES LTD: 7755 units of Ordinary Shares, dated 2026-11-09. The full Form 4 contains 5 transaction entries.
SELF
BURKE RUSSELL E III reported 2,748 shares of Common Stock in Global Self Storage, Inc. as grants or awards dated 2026-11-10. The Form 4 was disclosed on Nov 12, 2026. These were stock awards, not open-market purchases.
DTIL
Scimeca Dario reported Sale in PRECISION BIOSCIENCES INC: 2821 units of Common Stock, dated 2026-11-10. The full Form 4 contains 1 transaction entry.
OUST
Heystee Susan reported Sale in Ouster, Inc.: 7551 units of Common Stock, dated 2026-11-10. The full Form 4 contains 1 transaction entry.
FNF
Shea Peter O Jr reported 6,217 shares of Common Stock in Fidelity National Financial, Inc. as grants or awards dated 2026-11-09. The Form 4 was disclosed on Nov 12, 2026. These were stock awards, not open-market purchases.
TEVA
Sabag Mark reported Exercise or conversion in TEVA PHARMACEUTICAL INDUSTRIES LTD: 44710 units of Ordinary Shares, dated 2026-11-12. The full Form 4 contains 3 transaction entries.
FNF
THOMPSON CARY H reported 6,217 shares of Common Stock in Fidelity National Financial, Inc. as grants or awards dated 2026-11-09. The Form 4 was disclosed on Nov 12, 2026. These were stock awards, not open-market purchases.
OPCH
Pate R Carter reported Sale in Option Care Health, Inc.: 6092 units of Common Stock, dated 2026-11-10. The full Form 4 contains 2 transaction entries.
CSTL
Juvenal Tobin W reported Sale in CASTLE BIOSCIENCES INC: 3288 units of Common Stock, dated 2026-11-09. The full Form 4 contains 2 transaction entries.
LYEL
Bulis Veronica Sanchez reported Sale in Lyell Immunopharma, Inc.: 416 units of Common Stock, dated 2026-11-10. The full Form 4 contains 1 transaction entry.
TEVA
Francis Richard D reported Sale in TEVA PHARMACEUTICAL INDUSTRIES LTD: 250000 units of Ordinary Shares, dated 2026-11-10. The full Form 4 contains 1 transaction entry.